These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 27912737)

  • 21. Mitigating the burden of hepatitis C virus among people who inject drugs in Belgium.
    Matheï C; Bourgeois S; Blach S; Brixko C; Mulkay JP; Razavi H; Robaeys G
    Acta Gastroenterol Belg; 2016; 79(2):227-32. PubMed ID: 27382943
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High variability of HIV and HCV seroprevalence and risk behaviours among people who inject drugs: results from a cross-sectional study using respondent-driven sampling in eight German cities (2011-14).
    Wenz B; Nielsen S; Gassowski M; Santos-Hövener C; Cai W; Ross RS; Bock CT; Ratsch BA; Kücherer C; Bannert N; Bremer V; Hamouda O; Marcus U; Zimmermann R;
    BMC Public Health; 2016 Sep; 16(1):927. PubMed ID: 27595567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV treatment as prevention among people who inject drugs - a re-evaluation of the evidence.
    Fraser H; Mukandavire C; Martin NK; Hickman M; Cohen MS; Miller WC; Vickerman P
    Int J Epidemiol; 2017 Apr; 46(2):466-478. PubMed ID: 27524816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mathematical Modeling of Hepatitis C Prevalence Reduction with Antiviral Treatment Scale-Up in Persons Who Inject Drugs in Metropolitan Chicago.
    Echevarria D; Gutfraind A; Boodram B; Major M; Del Valle S; Cotler SJ; Dahari H
    PLoS One; 2015; 10(8):e0135901. PubMed ID: 26295805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis C transmission and treatment as prevention - The role of the injecting network.
    Hellard M; McBryde E; Sacks Davis R; Rolls DA; Higgs P; Aitken C; Thompson A; Doyle J; Pattison P; Robins G
    Int J Drug Policy; 2015 Oct; 26(10):958-62. PubMed ID: 26072105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Understanding differences in HIV/HCV prevalence according to differentiated risk behaviors in a sample of PWID in rural Puerto Rico.
    Abadie R; Welch-Lazoritz M; Gelpi-Acosta C; Reyes JC; Dombrowski K
    Harm Reduct J; 2016 Mar; 13():10. PubMed ID: 26956029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An urgent need to scale-up injecting drug harm reduction services in Tanzania: prevalence of blood-borne viruses among drug users in Temeke District, Dar-es-Salaam, 2011.
    Bowring AL; Luhmann N; Pont S; Debaulieu C; Derozier S; Asouab F; Toufik A; van Gemert C; Dietze P; Stoove M
    Int J Drug Policy; 2013 Jan; 24(1):78-81. PubMed ID: 23036650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence and prevalence of hepatitis c virus infection among persons who inject drugs in New York City: 2006-2013.
    Jordan AE; Des Jarlais DC; Arasteh K; McKnight C; Nash D; Perlman DC
    Drug Alcohol Depend; 2015 Jul; 152():194-200. PubMed ID: 25891230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug scene, drug use and drug-related health consequences and responses in Kulob and Khorog, Tajikistan.
    Latypov A; Otiashvili D; Zule W
    Int J Drug Policy; 2014 Nov; 25(6):1204-14. PubMed ID: 25449057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trends in sources and sharing of needles among people who inject drugs, San Francisco, 2005-2012.
    Kim NJ; Jin H; McFarland W; Raymond HF
    Int J Drug Policy; 2015 Dec; 26(12):1238-43. PubMed ID: 26365768
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The status of hepatitis C virus infection among people who inject drugs in the Middle East and North Africa.
    Mahmud S; Mumtaz GR; Chemaitelly H; Al Kanaani Z; Kouyoumjian SP; Hermez JG; Abu-Raddad LJ
    Addiction; 2020 Jul; 115(7):1244-1262. PubMed ID: 32009283
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The cost of a late-detected outbreak among people who inject drugs. A modeling study.
    Gountas I; Hatzakis A; Nikolopoulos G; Touloumi G; Souliotis K
    Int J Drug Policy; 2021 Feb; 88():103032. PubMed ID: 33212371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospects for ending the HIV epidemic among persons who inject drugs in Haiphong, Vietnam.
    Des Jarlais DC; Thi Huong D; Thi Hai Oanh K; Khuê Pham M; Thi Giang H; Thi Tuyet Thanh N; Arasteh K; Feelemyer J; Hammett T; Peries M; Michel L; Vu Hai V; Roustide MJ; Moles JP; Laureillard D; Nagot N;
    Int J Drug Policy; 2016 Jun; 32():50-6. PubMed ID: 27006257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estimating the impact of a police education program on hepatitis C virus transmission and disease burden among people who inject drugs in Tijuana, Mexico: A dynamic modeling analysis.
    Rivera Saldana CD; Abramovitz D; Beletsky L; Borquez A; Kiene S; Marquez LK; Patton T; Strathdee S; Zúñiga ML; Martin NK; Cepeda J
    Addiction; 2023 Sep; 118(9):1763-1774. PubMed ID: 37039246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Global systematic review and ecological analysis of HIV in people who inject drugs: National population sizes and factors associated with HIV prevalence.
    Larney S; Leung J; Grebely J; Hickman M; Vickerman P; Peacock A; Stone J; Trickey A; Dumchev KV; Colledge S; Cunningham EB; Lynskey M; Mattick RP; Degenhardt L
    Int J Drug Policy; 2020 Mar; 77():102656. PubMed ID: 31951926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The contribution of unstable housing to HIV and hepatitis C virus transmission among people who inject drugs globally, regionally, and at country level: a modelling study.
    Stone J; Artenie A; Hickman M; Martin NK; Degenhardt L; Fraser H; Vickerman P
    Lancet Public Health; 2022 Feb; 7(2):e136-e145. PubMed ID: 35012711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Socio-demographic and ecological factors associated with anti-HCV prevalence in people who inject drugs: A systematic review.
    Colledge S; Leung J; Grebely J; Degenhardt L; Peacock A; Hickman M; Vickerman P; Stone J; Trickey A; Larney S
    Drug Alcohol Depend; 2020 Apr; 209():107899. PubMed ID: 32086179
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and correlates of HCV monoinfection and HIV and HCV coinfection among persons who inject drugs in Vietnam.
    Zhang L; Celentano DD; Le Minh N; Latkin CA; Mehta SH; Frangakis C; Ha TV; Mo TT; Sripaipan T; Davis WW; Quan VM; Go VF
    Eur J Gastroenterol Hepatol; 2015 May; 27(5):550-6. PubMed ID: 25769097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV, Hepatitis B and C among people who inject drugs: high prevalence of HIV and Hepatitis C RNA positive infections observed in Delhi, India.
    Ray Saraswati L; Sarna A; Sebastian MP; Sharma V; Madan I; Thior I; Pulerwitz J; Tun W
    BMC Public Health; 2015 Jul; 15():726. PubMed ID: 26223866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estimating HIV and HCV prevalence among people who inject drugs in 5 Ukrainian cities using stratification-based respondent driven and random sampling.
    Zelenev A; Shea P; Mazhnaya A; Meteliuk A; Pykalo I; Marcus R; Fomenko T; Prokhorova T; Altice FL
    Int J Drug Policy; 2019 May; 67():91-101. PubMed ID: 30503695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.